P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I‐DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018‐02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM).

Autor:	Macro, M., Touzeau, C., Mariette, C., Manier, S., Brechignac, S., Vincent, L., Hebraud, B., Decaux, O., Schulmann, S., Lenoir, C., Godmer, P., Farge, A., Peyro Saint Paul, L., Parienti, J.‐J., Leleu, X.
Zdroj:	HemaSphere; 2022 Supplement 3, Vol. 6, p819-820, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text